Expanding on Emerging Agents in GI Cancers in Dallas

Aug 22, 2018

This Dallas, Texas meeting on gastrointestinal (GI) cancers covered emerging therapies in pancreatic cancer, updates in neuroendocrine tumors, the management of metastatic colorectal cancer, recent data in hepatocellular carcinoma, and the clinical application of precision medicine in GI cancers.

We headed to Dallas, Texas for a State of the Science Summit on gastrointestinal (GI) malignancies. The meeting covered emerging therapies in pancreatic cancer, updates in neuroendocrine tumors, the management of metastatic colorectal cancer, recent data in hepatocellular carcinoma, and the clinical application of precision medicine in GI cancers.

Related Content